RESUMO
In the published article, the following information was missing.
RESUMO
Colorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment.
Assuntos
Sobreviventes de Câncer , Neoplasias do Colo/diagnóstico , Continuidade da Assistência ao Paciente , Recidiva Local de Neoplasia/diagnóstico , Vigilância da População , Neoplasias Retais/diagnóstico , Antineoplásicos/efeitos adversos , Antígeno Carcinoembrionário/análise , Neoplasias do Colo/patologia , Neoplasias do Colo/terapia , Colonoscopia , Feminino , Humanos , Neoplasias Hepáticas/diagnóstico por imagem , Neoplasias Hepáticas/secundário , Neoplasias Pulmonares/diagnóstico por imagem , Neoplasias Pulmonares/secundário , Masculino , Recidiva Local de Neoplasia/prevenção & controle , Estadiamento de Neoplasias , Oxaliplatina/efeitos adversos , Equipe de Assistência ao Paciente , Complicações Pós-Operatórias , Prevenção Primária , Radioterapia/efeitos adversos , Neoplasias Retais/patologia , Neoplasias Retais/terapia , Prevenção Secundária , Disfunções Sexuais Fisiológicas/etiologia , Fatores de TempoRESUMO
Correction to: Clin Transl Oncol https://doi.org/10.1007/s12094-017-1801-4.
RESUMO
The increased incidence and decreased mortality of breast cancer have produced an increased number of breast cancer survivors. The type of sequelae and comorbidities that these patients present call for a collaborative follow-up by hospital-based specialized care and primary care. In this document, we present a guideline drafted and agreed among scientific societies whose members care for breast cancer survivors. The purpose of this guideline is to achieve the shared and coordinated follow-up of these patients by specialized care and primary care professionals. In it, we review the health issues derived from the treatments performed, with recommendations about the therapeutic approach to each of them, as well as a proposal for joint follow-up by primary and specialized care.